The global emergence of Chikungunya infection: An integrated view-Reference-Cited by-同舟云学术

The global emergence of Chikungunya infection: An integrated view

Published:2021-08-24 Issue: Volume: Page:
ISSN:1052-9276
Container-title:Reviews in Medical Virology
language:en
Short-container-title:Rev Med Virol

Author:

Manzoor Khanzadi Nazneen¹,Javed Farakh²^ORCID,Ejaz Muhammad³^ORCID,Ali Mubashar³,Mujaddadi Neelam³,Khan Abid Ali⁴,Khattak Aamer Ali⁵,Zaib Assad⁵,Ahmad Ibrar⁶,Saeed Waqar Khalid²,Manzoor Sobia⁷

Affiliation:

1. Department of Biosciences COMSATS institute of Information Technology Islamabad Pakistan

2. Department of Biomedical Sciences Pak‐Autria Fachhochschule: Institute of Applied Sciences & Technology Haripur Pakistan

3. Department of Microbiology The University of Haripur Haripur Pakistan

4. Institute of Precision Medicine Hochschule Furtwangen University Furtwangen im Schwarzwald Germany

5. Department of Medical Lab Technology The University of Haripur Haripur Pakistan

6. Center for Human Genetics Hazara University Mansehra Pakistan

7. Atta‐ur‐Rehman school of applied biosciences National University of science and Technology Islamabad Pakistan

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/rmv.2287

Reference144 articles.

1. An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952‐53; an additional note on Chikungunya virus isolations and serum antibodies;Mason PJ;Trans R Soc Trop Med Hyg,1957

2. An epidemic of virus disease in Southern Province, Tanganyika territory, in 1952–1953

3. The Newala epidemic: III. The virus: isolation, pathogenic properties and relationship to the epidemic

4. Chikungunya, an epidemic arbovirosis

5. Two Chikungunya Isolates from the Outbreak of La Reunion (Indian Ocean) Exhibit Different Patterns of Infection in the Mosquito, Aedes albopictus

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medically Significant Vector-Borne Viral Diseases in Iran;Microorganisms;2023-12-18

2. A randomized, double-blinded Phase 3 study to demonstrate lot-to-lot consistency and to confirm immunogenicity and safety of the live-attenuated chikungunya virus vaccine candidate VLA1553 in healthy adults;Journal of Travel Medicine;2023-12-13

3. Cytokine profile, neutralisation potential and viral replication dynamics in sera of chikungunya patients in India: a cross-sectional study;The Lancet Regional Health - Southeast Asia;2023-12

4. Antiviral evaluation of 1,4-disubstituted-1,2,3-triazole derivatives against Chikungunya virus;Future Virology;2023-09

5. Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial;The Lancet;2023-06